Dworak Leiden 4
4 · TScan Therapeutics, Inc. · Filed Jul 24, 2023
Insider Transaction Report
Form 4
Dworak Leiden
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-07-21+25,000→ 25,000 totalExercise: $2.23Exp: 2033-07-20→ Voting Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of July 21, 2023, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.